As data on the prevalence of BRCA1/2 mutations matured, it became evident that pathogenic variants (PVs) in these genes accounted for less than two-thirds of hereditary breast cancer, leading to a search for additional breast cancer predisposition genes [5]. This evidence concerns the gene BRCA1 and breast cancer.